Yantai Dongcheng Pharmaceutical Co Ltd (002675) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.042x

Based on the latest financial reports, Yantai Dongcheng Pharmaceutical Co Ltd (002675) has a cash flow conversion efficiency ratio of 0.042x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥239.54 Million ≈ $35.05 Million USD) by net assets (CN¥5.66 Billion ≈ $827.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Yantai Dongcheng Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Yantai Dongcheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Yantai Dongcheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Yantai Dongcheng Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Yantai Dongcheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yantai Dongcheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Dalian Huarui Heavy Industry Group Co Ltd
SHE:002204
-0.016x
Odontoprev S.A
SA:ODPV3
0.005x
Bukit Asam Tbk PT
JK:PTBA
0.087x
Coursera Inc
NYSE:COUR
0.023x
Mesoblast Limited
F:LWB
-0.028x
Zhejiang Expressway Co. Ltd
F:ZHJ
0.012x
Maxvision Technology Corp
SHE:002990
0.031x
Solvac S.A.
BR:SOLV
0.011x

Annual Cash Flow Conversion Efficiency for Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see 002675 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.66 Billion
≈ $827.65 Million
CN¥584.61 Million
≈ $85.55 Million
0.103x +93.35%
2024-12-31 CN¥5.37 Billion
≈ $786.01 Million
CN¥287.15 Million
≈ $42.02 Million
0.053x +4.15%
2023-12-31 CN¥5.40 Billion
≈ $789.55 Million
CN¥276.94 Million
≈ $40.53 Million
0.051x -72.79%
2022-12-31 CN¥5.28 Billion
≈ $772.97 Million
CN¥996.54 Million
≈ $145.82 Million
0.189x +0.44%
2021-12-31 CN¥5.02 Billion
≈ $735.14 Million
CN¥943.58 Million
≈ $138.08 Million
0.188x +62.89%
2020-12-31 CN¥4.97 Billion
≈ $726.63 Million
CN¥572.58 Million
≈ $83.79 Million
0.115x -20.87%
2019-12-31 CN¥4.78 Billion
≈ $699.31 Million
CN¥696.38 Million
≈ $101.90 Million
0.146x +36.26%
2018-12-31 CN¥4.61 Billion
≈ $674.68 Million
CN¥493.06 Million
≈ $72.15 Million
0.107x +68.33%
2017-12-31 CN¥3.29 Billion
≈ $481.25 Million
CN¥208.94 Million
≈ $30.57 Million
0.064x -0.18%
2016-12-31 CN¥3.08 Billion
≈ $451.28 Million
CN¥196.28 Million
≈ $28.72 Million
0.064x +113.39%
2015-12-31 CN¥2.24 Billion
≈ $327.19 Million
CN¥66.69 Million
≈ $9.76 Million
0.030x -32.08%
2014-12-31 CN¥1.18 Billion
≈ $173.30 Million
CN¥52.00 Million
≈ $7.61 Million
0.044x +334.72%
2013-12-31 CN¥1.10 Billion
≈ $161.16 Million
CN¥-20.60 Million
≈ $-3.01 Million
-0.019x -142.66%
2012-12-31 CN¥1.02 Billion
≈ $148.60 Million
CN¥44.53 Million
≈ $6.52 Million
0.044x -90.38%
2011-12-31 CN¥304.42 Million
≈ $44.55 Million
CN¥138.83 Million
≈ $20.31 Million
0.456x +52.81%
2010-12-31 CN¥191.06 Million
≈ $27.96 Million
CN¥57.02 Million
≈ $8.34 Million
0.298x +257.54%
2009-12-31 CN¥140.43 Million
≈ $20.55 Million
CN¥-26.60 Million
≈ $-3.89 Million
-0.189x -136.16%
2008-12-31 CN¥79.34 Million
≈ $11.61 Million
CN¥41.57 Million
≈ $6.08 Million
0.524x --

About Yantai Dongcheng Pharmaceutical Co Ltd

SHE:002675 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.56 Billion
CN¥10.68 Billion CNY
Market Cap Rank
#6963 Global
#1436 in China
Share Price
CN¥12.95
Change (1 day)
+1.01%
52-Week Range
CN¥12.24 - CN¥18.29
All Time High
CN¥27.09
About

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti… Read more